Granted Patent B2

US 12,496,307 · App. 17/594,830 · Granted Dec 16, 2025

Inventors: Elliot Altman (Rockvale, TN); Matthew Fuller (Murfreesboro, TN); Gheda Alsaif (Hail, SA); Shannon Smith (Murfreesboro, TN); Karen Maynard (Murfreesboro, TN); Anthony Farone (Murfreesboro, TN)

Assignee: GREENWAY HERBAL PRODUCTS, LLC

A61K31/658A61K45/06

Abstract

Claims (23)

1 . A method of administering a pharmaceutical composition comprising a cannabinoid mixture, wherein the cannabinoid mixture has an approximately 1:1 equimolar mixture of CBD:CBDA, and wherein the cannabinoid mixture comprises 1% or less of cannabinoids other than the CBD and CBDA, comprising administering an effective amount of the pharmaceutical composition for treating inflammation or autoimmunity in a subject.

2 . A method for treating at least one of inflammation and autoimmunity in a subject, the method comprising administering, to the subject, a pharmaceutical composition comprising a cannabinoid mixture, wherein the cannabinoid mixture has an approximately 1:1 equimolar mixture of CBD:CBDA, and wherein the cannabinoid mixture comprises 1% or less of cannabinoids other than the CBD and CBDA.

3 . A method of treating at least one of:

rheumatoid arthritis;

Crohn's disease;

lupus erythematosus (SLE);

Sjögren syndrome;

immune thrombocytopenia purpura (ITP);

myasthenia gravis;

sarcoidosis;

Addison's disease;

autoimmune hepatitis;

Celiac disease;

Grave's disease;

idiopathic thrombocytopenia purpura;

multiple sclerosis;

primary biliary cirrhosis;

psoriatic disease;

scleroderma; or

systemic lupus in a subject, comprising administering, to the subject, a pharmaceutical composition comprising a cannabinoid mixture, wherein the cannabinoid mixture has an approximately 1:1 equimolar mixture of CBD:CBDA, and wherein the cannabinoid mixture comprises 1% or less of cannabinoids other than the CBD and CBDA.

4 . The method of claim 2 , wherein treating the at least one of inflammation or autoimmunity comprises treating or preventing a symptom of inflammation.

5 . The method of claim 1 , wherein the subject is a mammal.

6 . The method of claim 5 , wherein the subject is a human.

Assignments (5)

Continuity (2)

References Cited (48)